Description
-
Kisspeptin-10 is a synthetic decapeptide derived from the larger kisspeptin-1 protein (encoded by the KISS1 gene) that serves as a crucial regulator of the reproductive system. It is a potent stimulator of the hypothalamic-pituitary-gonadal (HPG) axis, working primarily by binding to the G-protein coupled receptor GPR54 (kisspeptin receptor) to trigger the release of reproductive hormones.
Key Functions and Benefits
-
Hormonal Stimulation: It directly triggers the release of Gonadotropin-Releasing Hormone (GnRH) from the hypothalamus, which subsequently boosts Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) levels.
-
Testosterone and Estrogen Support: By elevating LH and FSH, it effectively signals the gonads to increase the natural production of testosterone in men and estrogen in women.
-
Fertility Enhancement: Research shows it plays a vital role in regulating ovulation, initiating puberty, and maintaining overall reproductive health and spermatogenesis.
-
Metabolic and Libido Support: Beyond direct hormone production, it has been linked to improvements in sex drive, mood, and potentially body composition via downstream hormonal optimization.
Medical Uses and Research
-
FDA Approval: Kisspeptin-10 is currently not FDA-approved for general medical use or prescription and does not have an assigned brand name. It is classified as a research chemical.
-
Active Research: It is being extensively studied for various conditions, including:
-
Reproductive Disorders: Hypogonadotropic hypogonadism, delayed puberty, and hypothalamic amenorrhea (loss of periods).
-
Fertility Treatments: In vitro fertilization (IVF) protocols to safely trigger ovulation while minimizing the risk of Ovarian Hyperstimulation Syndrome (OHSS).
-
Low Testosterone: As an alternative to traditional Testosterone Replacement Therapy (TRT) to maintain natural testicular function and fertility.
-
Psychology and Mood: Research exploring its impact on sexual aversion, depression, and emotional processing.
-
Usage and Safety
-
Administration: In clinical research, it is typically administered via subcutaneous or intravenous injection due to its short half-life in the body.
-
Side Effects: The most common side effects include mild injection site reactions (redness or irritation), brief headaches, transient flushing, or mild nausea.
-
Status: It remains a “research-grade” substance and a compound of high interest in endocrinology. It is not approved for off-the-shelf human consumption and should only be utilized within authorized clinical research settings.
-


Reviews
There are no reviews yet.